Details of Disease

General Information of Disease (ID: DISB38M8)

Disease Name	Meningococcal infection
Synonyms	meningococcal disease; infections, Neisseria meningitidis; Neisseria meningitidis infection
Disease Class	1C1C: Meningococcal disease
Definition	Infections with bacteria of the species neisseria meningitidis.
Disease Hierarchy	DIS5QJ9S: Bacterial infection DISEM33Q: Infectious disease DISB38M8: Meningococcal infection
ICD Code	ICD-11 ICD-11: 1C1C
Disease Identifiers	MONDO ID MONDO_0005373 MESH ID D008589 UMLS CUI C0025303 MedGen ID 7537 SNOMED CT ID 23511006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 3 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Bexsero	DMW1YS3	Approved	Vaccine	[1]
Meningococcal groups A, C, Y and W-135 conjugate vaccine	DM2SR1J	Approved	NA	[2]
MenQuadfi	DMLR5EW	Approved	Vaccine	[3]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 8 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
GSK3536819A	DM8OUWJ	Phase 3	Vaccine	[4]
PF-06886992	DMYWVYV	Phase 3	NA	[5]
Heat shock protein vaccine	DM9OZU5	Phase 2	Vaccine	[6]
MenABCWY	DMDPL7Y	Phase 2	NA	[7]
Meninge ACYW	DMJCA5X	Phase 2	NA	[8]
NmVac-4 A/C/Y/W-135 DT	DM20OTZ	Phase 2	Vaccine	[9]
NmVac	DM34R3U	Phase 1	NA	[10]
NmVac4	DMKROI2	Phase 1	NA	[11]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
2	Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services.
4	ClinicalTrials.gov (NCT04502693) Study to Assess Effectiveness of GlaxoSmithKline's (GSK's) Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults.. U.S. National Institutes of Health.
5	Clinical pipeline report, company report or official report of Pfizer.
6	Clinical pipeline report, company report or official report of Agenus.
7	ClinicalTrials.gov (NCT01992536) Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03. U.S. National Institutes of Health.
8	Clinical pipeline report, company report or official report of Sanofi Pasteur.
9	ClinicalTrials.gov (NCT01897402) Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine. U.S. National Institutes of Health.
10	Clinical pipeline report, company report or official report of JN-International Medical.
11	Clinical pipeline report, company report or official report of JN-International Medical.